SKShigeto Kubo

Shigeto Kubo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shigeto Kubo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Primary Cardiac Lymphoma Demonstrated by Delayed Contrast-Enhanced Magnetic Resonance Imaging

    by Shigeto Kubo, Eiji Tadamura, Masaki Yamamuro, Makoto Motooka, Yasuaki Nakashima, Keiichi Tambara, Masashi Komeda, Junji Konishi

    Delayed contrast-enhanced magnetic resonance (MR) imaging that nullifies the signal of normal myocardium produces great differences in myocardial signal intensity between normal and infarcted myocardium. A case of primary cardiac lymphoma is presented in which delayed contrast-enhanced MR imaging clearly identified the localization and extension of a lymphoma infiltrating the myocardium.


    • 1 May 2004
      • Vol. 45  (5) , 730-8

    Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole.

    by Shigeto Kubo, Eiji Tadamura, Hiroshi Toyoda, Marcelo Mamede, Masaki Yamamuro, Yasuhiro Magata, Takahiro Mukai, Haruhiro Kitano, Nagara Tamaki, Junji Konishi

    The aims of this study were (a). to compare absolute myocardial blood flow (MBF) during adenosine triphosphate (ATP) infusion with that after dipyridamole administration without caffeine intake and (b). to evaluate the effect of caffeine intake on the hyperemic flow induced by these coronary vasodilator agents. MBF was quantified with (15)O-labeled water and PET at rest, during ATP infusion (0.16 mg/kg/min for 9 min), and after dipyridamole administration (0.56 mg/kg over 4 min) after a 24-h abstinence from caffeine (baseline evaluation) in 10 healthy volunteers. Within 2 wk, the same PET studies were repeated after caffeine intake to evaluate the effect of caffeine on the hyperemic flow induced by these pharmacologic agents (caffeine study). Myocardial flow reserve (MFR), defined as the ratio of hyperemic to resting blood flow, was also evaluated. Resting MBF in baseline and caffeine studies did not differ significantly (0.79 +/- 0.29 vs. 0.75 +/- 0.31 mL/min/g, P = 0.88). Without caffeine intake, MBF during ATP infusion was significantly higher than that after dipyridamole administration (3.70 +/- 0.67 vs. 3.00 +/- 0.79 mL/min/g, P = 0.003), whereas there was no significant difference in MFR between ATP and dipyridamole stress (5.15 +/- 1.64 vs. 4.11 +/- 1.44, P = 0.07). After caffeine intake, the hyperemic flows induced by ATP and dipyridamole were not significantly different (1.68 +/- 0.37 vs. 1.52 +/- 0.40 mL/min/g, P = 0.50). MFR estimated by ATP and dipyridamole also did not differ significantly in the caffeine studies (2.44 +/- 0.88 vs. 2.25 +/- 0.94, P = 0.73). MBF during ATP infusion and after dipyridamole administration were significantly lower in the caffeine studies than that in the baseline evaluation (1.68 +/- 0.37 vs. 3.70 +/- 0.67 mL/min/g, P < 0.0001, and 1.52 +/- 0.40 vs. 3.00 +/- 0.79 mL/min/g, P < 0.0001, respectively). This study demonstrates that ATP has the potential to induce greater hyperemia than dipyridamole, whereas hyperemic responses to ATP and dipyridamole are similarly attenuated after caffeine intake. These findings suggest that abstinence from caffeine before ATP stress testing may be needed.


  • Assessment of the effect of revascularization early after CABG using ECG-gated perfusion single-photon emission tomography.

    by Shigeto Kubo, Eiji Tadamura, Takashi Kudoh, Masayuki Inubushi, Tadashi Ikeda, Takaaki Koshiji, Kazunobu Nishimura, Masashi Komeda, Nagara Tamaki, Junji Konishi